Doxorubicin, Vinblastine, Dacarbazine, Brentuximab Vedotin, and Nivolumab in Treating Patients With Stage I-II Hodgkin Lymphoma

Name: Doxorubicin, Vinblastine, Dacarbazine, Brentuximab Vedotin, and Nivolumab in Treating Patients With Stage I-II Hodgkin Lymphoma
Published: 2017
License: Public Domain

Academic and Community Cancer Research United · 2017

ClinicalTrials.gov · Datasets · License: Public Domain · 2017

Open Source ↗

ann arbor stage i hodgkin lymphoma, ann arbor stage ia hodgkin lymphoma, ann arbor stage ib hodgkin lymphoma, ann arbor stage ii hodgkin lymphoma, ann arbor stage iia hodgkin lymphoma, ann arbor stage iib hodgkin lymphoma, classic hodgkin lymphoma, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Doxorubicin, Vinblastine, Dacarbazine, Brentuximab Vedotin, and Nivolumab in Treating Patients With Stage I-II Hodgkin Lymphoma

Related documents